Considerations in boosting COVID-19 vaccine immune responses
A new wave of COVID-19 cases caused by the highly transmissible delta variant is exacerbating the worldwide public health crisis, and has […]
Category: Uncategorized
COVID-19 will continue but the end of the pandemic is near
The world is experiencing a huge wave of infection with the omicron variant of SARS-CoV-2. Estimates based on Institute for Health Metrics […]
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
Visual benefits with faricimab given at up to 16-week intervals demonstrates its potential to meaningfully extend the time between treatments with sustained […]
Power and bullying in research
Eric Lander, director of the Office of Science and Technology Policy and science adviser to US President Joe Biden, resigned on Feb […]
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden
We found progressively waning vaccine effectiveness against SARS-CoV-2 infection of any severity across all subgroups, but the rate of waning differed according […]
Global, regional, and national prevalence estimates of physical or sexual, or both, intimate partner violence against women in 2018
These findings show that intimate partner violence against women was already highly prevalent across the globe before the COVID-19 pandemic. Governments are […]
Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021
Efforts to improve pandemic preparedness and response for the next pandemic might benefit from greater investment in risk communication and community engagement […]
Medical aid returns to Tigray
Shipments of medical supplies have been delivered to Tigray—the first in months—but WHO says it will not be enough to restock the […]
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol
Among men with high-risk non-metastatic prostate cancer, combination therapy is associated with significantly higher rates of metastasis-free survival compared with ADT alone. […]